182 related articles for article (PubMed ID: 20853109)
21. Whole-body MRI of multiple myeloma: comparison of different MRI sequences in assessment of different growth patterns.
Weininger M; Lauterbach B; Knop S; Pabst T; Kenn W; Hahn D; Beissert M
Eur J Radiol; 2009 Feb; 69(2):339-45. PubMed ID: 18096344
[TBL] [Abstract][Full Text] [Related]
22. Quantitative bone marrow magnetic resonance imaging through apparent diffusion coefficient and fat fraction in multiple myeloma patients.
Berardo S; Sukhovei L; Andorno S; Carriero A; Stecco A
Radiol Med; 2021 Mar; 126(3):445-452. PubMed ID: 32812173
[TBL] [Abstract][Full Text] [Related]
23. Intravoxel Incoherent Motion Diffusion-weighted Imaging of Multiple Myeloma Lesions: Correlation with Whole-Body Dynamic Contrast Agent-enhanced MR Imaging.
Bourillon C; Rahmouni A; Lin C; Belhadj K; Beaussart P; Vignaud A; Zerbib P; Pigneur F; Cuenod CA; Bessalem H; Cavet M; Boutekadjirt A; Haioun C; Luciani A
Radiology; 2015 Dec; 277(3):773-83. PubMed ID: 26131910
[TBL] [Abstract][Full Text] [Related]
24. [Use of whole-body diffusion-weighted magnetic resonance imaging for the diagnosis of and therapeutic response in multiple myeloma].
Puskás T; Henits I
Orv Hetil; 2014 Aug; 155(31):1241-5. PubMed ID: 25095285
[TBL] [Abstract][Full Text] [Related]
25. Pediatric whole-body magnetic resonance imaging: comparison of STIR and T2 Dixon sequences in the detection and grading of high signal bone marrow changes.
Zadig P; von Brandis E; Ording Müller LS; Tanturri de Horatio L; Rosendahl K; Avenarius DFM
Eur Radiol; 2023 Jul; 33(7):5045-5053. PubMed ID: 36700955
[TBL] [Abstract][Full Text] [Related]
26. High signal in bone marrow at diffusion-weighted imaging with body background suppression (DWIBS) in healthy children.
Ording Müller LS; Avenarius D; Olsen OE
Pediatr Radiol; 2011 Feb; 41(2):221-6. PubMed ID: 20652234
[TBL] [Abstract][Full Text] [Related]
27. Whole-body MRI in oncology: can a single anatomic T2 Dixon sequence replace the combination of T1 and STIR sequences to detect skeletal metastasis and myeloma?
Chiabai O; Van Nieuwenhove S; Vekemans MC; Tombal B; Peeters F; Wuts J; Triqueneaux P; Omoumi P; Kirchgesner T; Michoux N; Lecouvet FE
Eur Radiol; 2023 Jan; 33(1):244-257. PubMed ID: 35925384
[TBL] [Abstract][Full Text] [Related]
28. Apparent diffusion coefficient of vertebral haemangiomas allows differentiation from malignant focal deposits in whole-body diffusion-weighted MRI.
Winfield JM; Poillucci G; Blackledge MD; Collins DJ; Shah V; Tunariu N; Kaiser MF; Messiou C
Eur Radiol; 2018 Apr; 28(4):1687-1691. PubMed ID: 29134357
[TBL] [Abstract][Full Text] [Related]
29. Artifact-robust diffusion-weighted whole-body imaging with background suppression at 3 T using improved turbo spin-echo diffusion-weighted imaging.
Suzuki M; Morita S; Goto Y; Tadenuma H; Nishina Y; Yoneyama M; Tanaka I; Sakai S
Br J Radiol; 2019 Feb; 92(1094):20180489. PubMed ID: 30407840
[TBL] [Abstract][Full Text] [Related]
30. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
[TBL] [Abstract][Full Text] [Related]
31. Integrated Shimming Improves Lesion Detection in Whole-Body Diffusion-Weighted Examinations of Patients With Plasma Disorder at 3 T.
Zhang H; Xue H; Alto S; Hui L; Kannengiesser S; Berthold K; Jin Z
Invest Radiol; 2016 May; 51(5):297-305. PubMed ID: 26704452
[TBL] [Abstract][Full Text] [Related]
32. Differentiation of multiple myeloma and metastases: Use of axial diffusion-weighted MR imaging in addition to standard MR imaging at 3T.
Park GE; Jee WH; Lee SY; Sung JK; Jung JY; Grimm R; Son Y; Paek MY; Min CK; Ha KY
PLoS One; 2018; 13(12):e0208860. PubMed ID: 30557373
[TBL] [Abstract][Full Text] [Related]
33. Whole-body magnetic resonance imaging (WB-MRI) with diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) in prostate cancer: Prevalence and clinical significance of incidental findings.
Kumasaka S; Motegi S; Kumasaka Y; Nishikata T; Otomo M; Tsushima Y
Br J Radiol; 2022 Mar; 95(1131):20210459. PubMed ID: 34111963
[TBL] [Abstract][Full Text] [Related]
34. T2-weighted Dixon MRI of the spine: A feasibility study of quantitative vertebral bone marrow analysis.
Donners R; Hirschmann A; Gutzeit A; Harder D
Diagn Interv Imaging; 2021; 102(7-8):431-438. PubMed ID: 33612414
[TBL] [Abstract][Full Text] [Related]
35. Detection of Traumatic Bone Marrow Lesions after Knee Trauma: Comparison of ADC Maps Derived from Diffusion-weighted Imaging with Standard Fat-saturated Proton Density-weighted Turbo Spin-Echo Sequences.
Klengel A; Stumpp P; Klengel S; Böttger I; Rönisch N; Kahn T
Radiology; 2017 May; 283(2):469-477. PubMed ID: 27775896
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic performance of
Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
[TBL] [Abstract][Full Text] [Related]
37. Diffusion-weighted whole body imaging with background body signal suppression/T2 image fusion is negative for patients with intraductal papillary mucinous neoplasm.
Tomizawa M; Shinozaki F; Motoyoshi Y; Sugiyama T; Yamamoto S; Ishige N
Hepatogastroenterology; 2015; 62(138):463-5. PubMed ID: 25916083
[TBL] [Abstract][Full Text] [Related]
38. What is the most effective tool for detecting prostate cancer using a standard MR scanner?
Osugi K; Tanimoto A; Nakashima J; Shinoda K; Hashiguchi A; Oya M; Jinzaki M; Kuribayashi S
Magn Reson Med Sci; 2013 Dec; 12(4):271-80. PubMed ID: 24172787
[TBL] [Abstract][Full Text] [Related]
39. Diffusion-weighted whole-body MR imaging with background body signal suppression: a feasibility study at 3.0 Tesla.
Mürtz P; Krautmacher C; Träber F; Gieseke J; Schild HH; Willinek WA
Eur Radiol; 2007 Dec; 17(12):3031-7. PubMed ID: 17646990
[TBL] [Abstract][Full Text] [Related]
40. Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: preliminary results.
Horger M; Weisel K; Horger W; Mroue A; Fenchel M; Lichy M
AJR Am J Roentgenol; 2011 Jun; 196(6):W790-5. PubMed ID: 21606271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
